Navigation Links
UCSD study reveals how plants respond to elevated carbon dioxide

t carbon dioxide responsiveness, and understanding the underlying mechanisms may make it possible to engineer improved water use efficiency in some crop plants or trees that will be exposed to higher carbon dioxide levels in the future."

In the paper, the researchers also report the discovery of the first known plant with a genetic mutation that makes it strongly insensitive to increased levels of carbon dioxide, which will provide additional information about the mechanism of plants' response to carbon dioxide levels. However, the researchers caution that a number of factors in addition to future atmospheric carbon dioxide concentrations, such as temperature, precipitation and available nutrient levels, will need to be considered before it will be possible to thoughtfully predict plant behavior based on molecular mechanisms.

"These molecular mechanisms are like fundamental parts of machinery," explained Young. "It's hard to predict what an instrument will do, if you don't even know anything about the parts that it is made from. Identify and characterize the parts, and you can figure out how they fit together to generate the structure of the machine, and from there you can figure out what it will do when you push button A or pull lever B."
'"/>

Source:University of California - San Diego


Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCSD study reveals how plants respond elevated carbon dioxide

(Date:7/25/2014)... SPRINGS, Florida , July 25, 2014 ... as more consumers are turning to digital technology for ... Inc. (OTCBB: NXTD), Google Inc. (NASDAQ: GOOG ... Inc. (NYSE: V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication ...
(Date:7/24/2014)... 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced ... control Phase 3 study of Zerenex (ferric citrate), the ... treatment of hyperphosphatemia in patients with end-stage renal disease ... iRon delivery with FErric CiTrate in EsrD) was published ... Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... for food or commercial food sale, has been heavily ... of many species of primates and other mammals. ... of the species being consumed are birds, particularly large ... the meat made available for sale but the meat ... and brought to villages for consumption, we noted a ...
Breaking Biology News(10 mins):Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... journals need to ensure that their peer reviewers act ... to new guidelines launched by the Committee on Publication ... Reviewers set out the basic principles and standards that ... "Peer review plays an important role in ...
... power grids is challenging because fluctuating wind speed and ... varying power demand, many wind-farm managers end up wasting ... through active control including fully stopping turbines ... the power grid from spikes in supply. In a ...
... in a particular cellular pathway are linked with bladder ... early online in CANCER , a peer- reviewed ... help improve bladder cancer screening and treatment. Alterations ... is important for various cellular processes, have been implicated ...
Cached Biology News:Committee on Publication Ethics launches ethical guidelines for peer reviewers 2Genetic alterations linked with bladder cancer risk, recurrence, progression, and patient survival 2
(Date:7/25/2014)... IN (PRWEB) July 25, 2014 At ... (FAA) has granted a 60-day extension for the public ... the Special Rule for Model Aircraft established by Congress ... of 2012. The 60-day extension establishes the new deadline ... United States Department of Transportation/FAA notice published in the ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... July 24, 2014 Gain recognition ... Supply Chain of the biotech industry. Nominations are ... Awards, brought to you by the Bio ... of supply chain management professionals for the past ... stakeholders of the Biotech industry – Manufacturers, Service ...
(Date:7/24/2014)... , July 24, 2014  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, announced today ... a presentation to investors on Tuesday, July 29, ...  The presentation will include an overview of Asterias, ... the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at least ...
Breaking Biology Technology:FAA Grants Comment Extension at the Request of AMA 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... to continue integration and expansion of PFPA,s IT ... - SRA International, Inc.,(NYSE: SRX ), a ... solutions to government organizations and commercial clients,today announced ... the Pentagon Force,Protection Agency (PFPA) Life Safety Security ...
... 11, 2008 at 9:55 a.m. EST, CHICAGO, Nov. 4 ... that O.B. Parrish, the Company,s Chief,Executive Officer, and Donna Felch, ... Annual Global Investment Conference at 9:55,a.m. Eastern Time on November ... Palace Hotel in New York City., A live audio ...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today ... a pivotal (Phase II/III) randomized trial using ... with head and neck cancers. The decision ... the Company,s Board of Directors from the ...
Cached Biology Technology:SRA Awarded $56 Million Contract by Pentagon Force Protection Agency 2The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference 2The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference 3Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial 2